ANI And Alimera Merger Moves Ahead Following Fleeting Legal Wrangle
Delay Was ‘Result Of Discussions For Closing Conditions,’ Which Have Been Resolved
With a date now in the diary for the merger to complete, ANI had insisted that it was working in good faith to close its June agreement with Alimera Sciences, which includes an upfront consideration of $380m.
